Ho Chi Minh City, Vietnam – June 2026 – Hunan Shangcheng Biotechnology Co., Ltd. successfully concluded its participation in the 2026 Vietnam International Pet Expo, where the company welcomed visitors from across Southeast Asia and further strengthened its presence in one of the region’s fastest-growing pet healthcare markets.
Throughout the three-day exhibition, Shangcheng showcased a comprehensive range of companion animal healthcare products, including antiparasitic treatments, anti-infective medicines, dermatology and otology products, and nutritional solutions. Visitors from veterinary clinics, distributors, and pet industry companies showed strong interest in the company’s products and explored opportunities for long-term cooperation.
The exhibition provided an excellent platform for strengthening relationships with existing partners while establishing new business connections across Southeast Asia. Through productive discussions on product development, market expansion, and distribution opportunities, Shangcheng reached multiple preliminary cooperation agreements and further enhanced its brand recognition in the region.
Backed by more than 50 years of experience in animal healthcare, Shangcheng Biotechnology integrates research and development, manufacturing, and global distribution to provide reliable veterinary solutions for customers worldwide. The company operates a 30,000-square-meter manufacturing facility, 16 GMP-certified production lines, and multiple R&D centers across China, ensuring consistent product quality and continuous innovation.
The successful conclusion of the Vietnam International Pet Expo marks another important milestone in Shangcheng’s global expansion. Looking ahead, the company will continue to invest in innovation, strengthen partnerships with customers around the world, and deliver high-quality animal health products that help improve the well-being of animals and support healthier, longer lives for companion animals.
